HSP90AA1 and breast cancer: Hunter et al. showed that adding exogenous Hsp90 to the conditioned media of breast cancer cells resulted in increased FN deposition, while inhibition of Hsp90 using a C-terminal inhibitor (Novobiocin) and siRNA reduced the FN levels in the ECM matrix [25].